BRPI0513743B8 - forma farmacêutica multicamada, seu uso e seu processo de produção - Google Patents
forma farmacêutica multicamada, seu uso e seu processo de produçãoInfo
- Publication number
- BRPI0513743B8 BRPI0513743B8 BRPI0513743A BRPI0513743A BRPI0513743B8 BR PI0513743 B8 BRPI0513743 B8 BR PI0513743B8 BR PI0513743 A BRPI0513743 A BR PI0513743A BR PI0513743 A BRPI0513743 A BR PI0513743A BR PI0513743 B8 BRPI0513743 B8 BR PI0513743B8
- Authority
- BR
- Brazil
- Prior art keywords
- percent
- weight
- monomers
- medicament
- blowing agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
medicamento em uma forma de multicamada. a presente invenção refere-se a um medicamento em uma forma de multicamada, que contém a) um núcleo com um agente farmacêutico, b) uma cobertura interna, 50 a 95 por cento em peso da qual são compostos de um (co)polímero que compreende 95 a 100 por cento em peso de monômeros vinílicos radicalmente polimerizados com grupos laterais neutros e 0 a 5 por cento em peso de monômeros com grupos laterais aniônicos, c) uma cobertura externa feita de um copolímero que compreende de 75 a 95 por cento em peso de ésteres de c~ 1~a c~ 4~ alquila radicalmente polimerizados de ácido acrílico ou ácido metacrílico e 5 a 25 por cento em peso de monômeros de (met)acrílato com um grupo aniônico no radical alquila. o referido medicamento também contém 5 a 30 por cento em peso de auxiliares farmacêuticos comuns, particularmente emolientes. o medicamento inventivo é caracterizado pelo fato de que a cobertura interna contém 5 a 50 por cento em peso de auxiliares farmacêuticos comuns que são agentes de nenhuma expansão, enquanto que a quantidade de agentes de expansão fornecida é menor do que 5 por cento em peso.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004035936.9 | 2004-07-23 | ||
| DE102004035936A DE102004035936A1 (de) | 2004-07-23 | 2004-07-23 | Mehrschichtige Arzneiform |
| PCT/EP2005/005374 WO2006010394A2 (de) | 2004-07-23 | 2005-05-18 | Mehrschichtige arzneiform |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0513743A BRPI0513743A (pt) | 2008-05-13 |
| BRPI0513743B1 BRPI0513743B1 (pt) | 2018-05-15 |
| BRPI0513743B8 true BRPI0513743B8 (pt) | 2021-05-25 |
Family
ID=35786554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0513743A BRPI0513743B8 (pt) | 2004-07-23 | 2005-05-18 | forma farmacêutica multicamada, seu uso e seu processo de produção |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100151010A1 (pt) |
| EP (1) | EP1781263B1 (pt) |
| JP (1) | JP5534643B2 (pt) |
| KR (2) | KR20070034067A (pt) |
| CN (1) | CN1972674B (pt) |
| AT (1) | ATE409464T1 (pt) |
| BR (1) | BRPI0513743B8 (pt) |
| CA (1) | CA2570277C (pt) |
| DE (2) | DE102004035936A1 (pt) |
| ES (1) | ES2314662T3 (pt) |
| IL (1) | IL180849A (pt) |
| MX (1) | MX2007000954A (pt) |
| PL (1) | PL1781263T3 (pt) |
| SI (1) | SI1781263T1 (pt) |
| WO (1) | WO2006010394A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG174026A1 (en) | 2006-08-03 | 2011-09-29 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease |
| WO2009154810A2 (en) * | 2008-02-25 | 2009-12-23 | Dr. Reddy's Laboratories Ltd. | Delivery systems for multiple active agents |
| CA2717947C (en) | 2008-03-11 | 2020-07-07 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
| EP2309999A1 (en) * | 2008-06-26 | 2011-04-20 | McNeil-PPC, Inc. | Coated particles containing pharmaceutically active agents |
| US9795576B2 (en) * | 2010-09-27 | 2017-10-24 | Basf Se | Protective coatings for acidic active ingredients |
| CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US20160220498A1 (en) * | 2015-01-29 | 2016-08-04 | Aneesh SONI | Fully or partially biodegradable device for controlled drug delivery |
| JP6824197B2 (ja) | 2015-06-05 | 2021-02-03 | エボニック オペレーションズ ゲーエムベーハー | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CN107712706A (zh) * | 2017-09-27 | 2018-02-23 | 福建永生活力生物工程有限公司 | 小球藻刺梨复合片及其制备方法 |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0520119A1 (de) * | 1991-06-17 | 1992-12-30 | Spirig Ag Pharmazeutische Präparate | Neue orale Diclofenaczubereitung |
| CA2148465C (en) * | 1992-11-06 | 1999-11-02 | Minenobu Okayama | Oral pharmaceutical preparation releasable in the lower digestive tract |
| US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
| SK287902B6 (sk) * | 2001-01-31 | 2012-03-02 | Evonik Rohm Gmbh | Multiparticulate drug form and method for the preparation thereof |
| SK9132003A3 (en) * | 2001-12-19 | 2004-02-03 | Astrazeneca Ab | A film coating composition, a coating film, pharmaceutical formulation comprising same and a process for its production |
| DE10214002A1 (de) * | 2002-03-27 | 2003-10-09 | Roehm Gmbh | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
| DE10250543A1 (de) * | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
-
2004
- 2004-07-23 DE DE102004035936A patent/DE102004035936A1/de not_active Withdrawn
-
2005
- 2005-05-18 AT AT05746448T patent/ATE409464T1/de active
- 2005-05-18 KR KR1020077001502A patent/KR20070034067A/ko not_active Ceased
- 2005-05-18 US US11/569,731 patent/US20100151010A1/en not_active Abandoned
- 2005-05-18 MX MX2007000954A patent/MX2007000954A/es active IP Right Grant
- 2005-05-18 KR KR1020137008029A patent/KR101739166B1/ko not_active Expired - Fee Related
- 2005-05-18 DE DE502005005559T patent/DE502005005559D1/de not_active Expired - Lifetime
- 2005-05-18 EP EP05746448A patent/EP1781263B1/de not_active Expired - Lifetime
- 2005-05-18 BR BRPI0513743A patent/BRPI0513743B8/pt not_active IP Right Cessation
- 2005-05-18 CA CA2570277A patent/CA2570277C/en not_active Expired - Lifetime
- 2005-05-18 JP JP2007521807A patent/JP5534643B2/ja not_active Expired - Fee Related
- 2005-05-18 WO PCT/EP2005/005374 patent/WO2006010394A2/de not_active Ceased
- 2005-05-18 SI SI200530505T patent/SI1781263T1/sl unknown
- 2005-05-18 CN CN2005800210723A patent/CN1972674B/zh not_active Expired - Fee Related
- 2005-05-18 PL PL05746448T patent/PL1781263T3/pl unknown
- 2005-05-18 ES ES05746448T patent/ES2314662T3/es not_active Expired - Lifetime
-
2007
- 2007-01-22 IL IL180849A patent/IL180849A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070034067A (ko) | 2007-03-27 |
| BRPI0513743A (pt) | 2008-05-13 |
| US20100151010A1 (en) | 2010-06-17 |
| JP2008507482A (ja) | 2008-03-13 |
| KR20130046448A (ko) | 2013-05-07 |
| BRPI0513743B1 (pt) | 2018-05-15 |
| IL180849A0 (en) | 2007-07-04 |
| CA2570277A1 (en) | 2006-02-02 |
| WO2006010394A3 (de) | 2006-09-08 |
| EP1781263A2 (de) | 2007-05-09 |
| JP5534643B2 (ja) | 2014-07-02 |
| EP1781263B1 (de) | 2008-10-01 |
| CN1972674B (zh) | 2010-05-12 |
| WO2006010394A2 (de) | 2006-02-02 |
| DE102004035936A1 (de) | 2006-03-16 |
| KR101739166B1 (ko) | 2017-05-23 |
| PL1781263T3 (pl) | 2009-04-30 |
| SI1781263T1 (sl) | 2009-02-28 |
| CA2570277C (en) | 2013-01-15 |
| CN1972674A (zh) | 2007-05-30 |
| MX2007000954A (es) | 2007-04-16 |
| ATE409464T1 (de) | 2008-10-15 |
| IL180849A (en) | 2010-11-30 |
| DE502005005559D1 (de) | 2008-11-13 |
| ES2314662T3 (es) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL180849A0 (en) | Medicament in a multilayer form | |
| BRPI0315740B8 (pt) | formas de dosagem com multicamadas que contêm substâncias ativas e que compreendem um núcleo neutro e um revestimento interno e externo composto por copolímeros de metacrilato e monômeros de metacrilato | |
| BRPI0416492A (pt) | forma farmacêutica multicamadas com uma matriz a qual influencia a distribuição de uma substáncia modulatória | |
| BRPI0416501A (pt) | forma de dosagem farmacêutica com múltiplas camadas contendo uma substáncia que age de uma forma modulatória, no que diz respeito á liberação das substáncias ativas | |
| BRPI0410956A (pt) | pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas | |
| BR0314036A (pt) | Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação | |
| AU6197499A (en) | Coated medicament forms with controlled active substance release | |
| BR9815861A (pt) | Composição farmacêutica com revestimento entérico e método de fabricação | |
| IL185218A0 (en) | Partly neutralised anionic (meth) acrylate copolymer | |
| MX356579B (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
| NO20031165D0 (no) | Sammensetning for transdermal levering av fentanyl | |
| KR950005301A (ko) | 방출 개시 제어 및 방출 속도 제어형 제제 | |
| ES2531252T3 (es) | Copolímeros aleatorios de metacrilatos y acrilatos | |
| BR112013028453B8 (pt) | Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro | |
| BR112013032095A2 (pt) | composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas | |
| BR112012013063A2 (pt) | polímero | |
| ES2193950T3 (es) | Sistemas de cloruro de vinilo polimerico de fases multiples y particulas de nucleo-envuelta. | |
| MX2010007578A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. | |
| MX2010007579A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. | |
| UA93530C2 (ru) | Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения | |
| TW200640952A (en) | Use of copolymers with a composition gradient as stabilizers in emulsion free-radical polymerization | |
| BR112021017735A2 (pt) | Forma de dosagem que compreende uma matriz polimérica | |
| BR112014026108A2 (pt) | composição cosmética e agente condicionador | |
| BR112018012197A2 (pt) | copolímeros de enxerto e composições dos mesmos | |
| PT91760A (pt) | Processo para a preparacao de primarios aquosos a base de copolimeros contendo grupos amino e destes copolimeros |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: EVONIK ROEHM GMBH (DE) Free format text: NOME ALTERADO DE: ROEHM GMBH |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B25D | Requested change of name of applicant approved | ||
| B25G | Requested change of headquarter approved | ||
| B25A | Requested transfer of rights approved | ||
| B25D | Requested change of name of applicant approved | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 20A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2827 DE 11-03-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |